Stock listing

Inmune Bio Inc.

Selected listing: A2PCBU · LS · EUR · DE

Inmune Bio Inc. (Lang & Schwarz: A2PCBU), Health Technology. Latest release Oct 6, 2026: INmune Bio to Attend the 2026 Maxim Growth Summit.

A2PCBU:LSEURDEUpdated October 2, 2026
Inmune Bio Inc. logo
Ticker
Lang & Schwarz: A2PCBU
Asset type
Stock
Sector
Health Technology
Industry
Biotechnology
Exchange
Lang & Schwarz
Currency
EUR

Latest news from Inmune Bio Inc.

INmune Bio to Attend the 2026 Maxim Growth Summit

October 6, 2026

INmune Bio Appoints Sanofi Rare-Disease Executive and Biopharma Business Development Leader to Board

September 14, 2026

INmune Bio to Present at the H.C. Wainwright Global Investment Conference

September 9, 2026

INmune Bio Advances Ebstrocel™ Toward European Marketing Authorization with EMA Regulatory Filings

August 26, 2026

INmune Bio Inc. Announces Second Quarter 2026 Results and Highlights Regulatory, Manufacturing and Clinical Progress

August 6, 2026

All Inmune Bio Inc. news →

Events

Replays

  • INmune Bio Inc. (INMB) Q2 2026 Earnings Call

    Thu, Aug 06, 2026 · 04:30 PM ET

    Watch

  • INmune Bio Inc. (INMB) Q1 2026 Earnings Call

    Thu, May 07, 2026 · 04:30 PM ET

    Watch

  • INmune Bio Inc. (INMB) Q4 2025 Earnings Call

    Mon, Mar 30, 2026 · 04:30 PM ET

    Watch

Research Inmune Bio Inc.

Inmune Bio Inc. company profile

View the public company page for Inmune Bio Inc. on 6ix.

Inmune Bio Inc. news

Read company news and market updates connected to Inmune Bio Inc..

Inmune Bio Inc. investor events

Find investor webinars, events, and replay context for Inmune Bio Inc..

Alternate listings

INMB:NASDAQ

US · USD

Alternate listing for Inmune Bio Inc.; the primary context on this page is A2PCBU:LS.

INMB:BOATS

US · USD

Alternate listing for Inmune Bio Inc.; the primary context on this page is A2PCBU:LS.

0Y2:TRADEGATE

DE · EUR

Alternate listing for Inmune Bio Inc.; the primary context on this page is A2PCBU:LS.